Stephanie Tanadini-Lang
Saliency-Enhanced Content-Based Image Retrieval for Diagnosis Support in Dermatology Consultation: Reader Study.
Gassner M, Barranco Garcia J, Tanadini-Lang S, Bertoldo F, Fröhlich F, Guckenberger M, Haueis S, Pelzer C, Reyes M, Schmithausen P, Simic D, Stäger R, Verardi F, Andratschke N, Adelmann A, Braun R. Saliency-Enhanced Content-Based Image Retrieval for Diagnosis Support in Dermatology Consultation: Reader Study. JMIR Dermatol 2023; 6:e42129.
24.08.2023Saliency-Enhanced Content-Based Image Retrieval for Diagnosis Support in Dermatology Consultation: Reader Study.
24.08.2023JMIR Dermatol 2023; 6:e42129
Gassner Mathias, Barranco Garcia Javier, Tanadini-Lang Stephanie, Bertoldo Fabio, Fröhlich Fabienne, Guckenberger Matthias, Haueis Silvia, Pelzer Christin, Reyes Mauricio, Schmithausen Patrick, Simic Dario, Stäger Ramon, Verardi Fabio, Andratschke Nicolaus, Adelmann Andreas, Braun Ralph
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiother Oncol 2020; 150:62-69.
12.06.2020Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
12.06.2020Radiother Oncol 2020; 150:62-69
Riesterer Oliver, Pruschy Martin, Bender Sabine, Sharma Ashish, Bogowicz Marta, Tanadini-Lang Stephanie, Stieb Sonja, Bertogg Kaja, Weber Sandra, Ikenberg Kristian, Huber Gerhard, Schmid Stephan, Bredell Marius, Veit-Haibach Patrick, Rordorf Tamara, Held Ulrike, Glanzmann Christoph, Studer Gabriela
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
de Galiza Barbosa F, Stolzmann P, Huellner M, Huber G, Pruschy M, Studer G, Stieb S, Tanadini-Lang S, Riesterer O, Veit-Haibach P. Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma. Head & neck 2019; 42:163-170.
09.11.2019Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
09.11.2019Head & neck 2019; 42:163-170
de Galiza Barbosa Felipe, Stolzmann Paul, Huellner Martin W, Huber Gerhard, Pruschy Martin, Studer Gabriela, Stieb Sonja, Tanadini-Lang Stephanie, Riesterer Oliver, Veit-Haibach Patrick